Yildirim N - Search Results

1

Prognostic role of pretreatment platelet/lymphocyte ratio in patients with non-small cell lung cancer.

Kos M, Hocazade C, Kos FT, Uncu D, Karakas E, Dogan M, Uncu HG, Yildirim N, Zengin N. Kos M, et al. Among authors: yildirim n. Wien Klin Wochenschr. 2016 Sep;128(17-18):635-40. doi: 10.1007/s00508-015-0724-8. Epub 2015 Feb 27. Wien Klin Wochenschr. 2016. PMID: 25720573

2

Adjuvant chemotherapy outcomes in patients over 65 years with early stage colorectal carcinoma.

Civelek B, Aksoy S, Sendur MA, Yazici O, Kanmaz H, Kos FT, Yildirim N, Uncu D, Zengin N. Civelek B, et al. Among authors: yildirim n. J BUON. 2014 Oct-Dec;19(4):906-12. J BUON. 2014. PMID: 25536594 Free article.

3

Primary duodenal diffuse large cell non-hodgkin lymphoma with involvement of ampulla of Vater: report of 3 cases.

Yildirim N, Oksüzoğlu B, Budakoğlu B, Vural M, Abali H, Uncu D, Zengin N. Yildirim N, et al. Hematology. 2005 Oct;10(5):371-4. doi: 10.1080/10245330500168773. Hematology. 2005. PMID: 16273723 Free article.

4

Disclosure of cancer diagnosis to patients and their relatives in Turkey: views of accompanying persons and influential factors in reaching those views.

Oksüzoğlu B, Abali H, Bakar M, Yildirim N, Zengin N. Oksüzoğlu B, et al. Among authors: yildirim n. Tumori. 2006 Jan-Feb;92(1):62-6. doi: 10.1177/030089160609200110. Tumori. 2006. PMID: 16683385

5

Capecitabine and cisplatin combination is an active and well-tolerated doublet in the treatment of metastatic breast carcinoma patients pretreated with anthracycline and taxanes.

Oksuzoglu B, Abali H, Hayran M, Yildirim N, Budakoglu B, Zengin N. Oksuzoglu B, et al. Among authors: yildirim n. Chemotherapy. 2008;54(5):352-6. doi: 10.1159/000151630. Epub 2008 Aug 26. Chemotherapy. 2008. PMID: 18728366 Clinical Trial.

6

Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma.

Abali H, Urün Y, Oksüzoğlu B, Budakoğlu B, Yildirim N, Güler T, Ozet G, Zengin N. Abali H, et al. Among authors: yildirim n. Cancer Invest. 2008 May;26(4):401-6. doi: 10.1080/07357900701788098. Cancer Invest. 2008. PMID: 18443961

7

Case report: cavernous sinus metastasis of the parotid carcinoma: a very unusual case.

Yildirim N, Oksüzoğlu B, Vural M, Han O, Zengin N. Yildirim N, et al. J Neurooncol. 2005 Jun;73(2):181-3. doi: 10.1007/s11060-004-4035-6. J Neurooncol. 2005. PMID: 15981110

8

Long-term outcomes of prolonged bisphosphonates more than 2 years in bone metastatic breast cancer: risk vs benefit.

Bal O, Oksuzoglu B, Dogan M, Durnali A, Uyeturk U, Demirci A, Arslan UY, Ekinci AS, Yildirim N, Alkis N, Kilic S. Bal O, et al. Among authors: yildirim n. Ir J Med Sci. 2020 Aug;189(3):805-810. doi: 10.1007/s11845-019-02120-6. Epub 2019 Dec 10. Ir J Med Sci. 2020. PMID: 31823174

9

Good tolerance of weekly irinotecan in a patient with metastatic colorectal cancer on chronic hemodialysis.

Budakoglu B, Abali H, Uncu D, Yildirim N, Oksüzoglu B, Zengin N. Budakoglu B, et al. Among authors: yildirim n. J Chemother. 2005 Aug;17(4):452-3. doi: 10.1179/joc.2005.17.4.452. J Chemother. 2005. PMID: 16167527

10

Blood flow indices by Doppler ultrasonography vary with neoadjuvant chemotherapy but are not related to plasma VEGF levels in locally advanced breast cancer.

Oksuzoğlu B, Vural M, Abali H, Yilmaz M, Yildirim N, Zengin N. Oksuzoğlu B, et al. Among authors: yildirim n. Oncology. 2006;71(3-4):185-9. doi: 10.1159/000106067. Epub 2007 Jul 18. Oncology. 2006. PMID: 17641536

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

475 results

Search Page

Filters